We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Envista
NVST
$4.01B
| $2.53M | 0.01% |
74,804
+352
| +0.5% | +$12.4K |
|
|
NEE.PRQ
877
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
| $2.53M | 0.01% |
+51,500
| New | +$2.51M |
|
878
Hubbell
HUBB
$23.2B
| $2.5M | 0.01% |
7,547
-340
| -4% | -$94.1K |
|
879
First Commonwealth Financial
FCF
$2.14B
| $2.49M | 0.01% |
197,140
+61,833
| +46% | +$780K |
|
|
BRSP
880
BrightSpire Capital
BRSP
$543M
| $2.48M | 0.01% |
+369,150
| New | +$2.19M |
|
881
Dolby
DLB
$5.5B
| $2.47M | 0.01% |
29,537
+8,052
| +37% | +$673K |
|
882
ADMA Biologics
ADMA
$1.99B
| $2.44M | 0.01% |
661,614
-250,348
| -27% | -$928K |
|
|
AHRT
883
AH Realty Trust
AHRT
$467M
| $2.42M | 0.01% |
207,252
-5,046
| -2% | -$58.9K |
|
|
AEL
884
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.42M | 0.01% |
46,424
-147,282
| -76% | -$5.92M |
|
885
Ball Corp
BALL
$16.2B
| $2.41M | 0.01% |
41,486
+12,051
| +41% | +$653K |
|
886
Ingredion
INGR
$6.21B
| $2.4M | 0.01% |
22,648
-158
| -0.7% | -$16.8K |
|
887
Kforce
KFRC
$935M
| $2.39M | 0.01% |
38,155
-2,319
| -6% | -$140K |
|
888
Helios Technologies
HLIO
$2.21B
| $2.38M | 0.01% |
35,979
+13,032
| +57% | +$772K |
|
889
Corning
GLW
$124B
| $2.37M | 0.01% |
67,722
+46,842
| +224% | +$1.54M |
|
890
Dick's Sporting Goods
DKS
$11B
| $2.37M | 0.01% |
17,914
+9,452
| +112% | +$1.29M |
|
|
INFA
891
DELISTED
Informatica
INFA
| $2.36M | 0.01% |
127,579
-1,848
| -1% | -$30.5K |
|
892
Fluence Energy
FLNC
$1.3B
| $2.36M | 0.01% |
88,436
+64,713
| +273% | +$1.45M |
|
893
Cable One
CABO
$107M
| $2.35M | 0.01% |
3,584
-75
| -2% | -$50.6K |
|
894
Myers Industries
MYE
$1.16B
| $2.35M | 0.01% |
121,147
-9,658
| -7% | -$190K |
|
895
Freshworks
FRSH
$3.32B
| $2.35M | 0.01% |
+133,577
| New | +$2.01M |
|
896
Phathom Pharmaceuticals
PHAT
$622M
| $2.35M | 0.01% |
+163,956
| New | +$1.89M |
|
|
PRFT
897
DELISTED
Perficient Inc
PRFT
| $2.34M | 0.01% |
+28,125
| New | +$2.07M |
|
898
Cummins
CMI
$72.6B
| $2.3M | 0.01% |
9,400
-17,516
| -65% | -$3.97M |
|
899
Atea Pharmaceuticals
AVIR
$413M
| $2.3M | 0.01% |
613,990
-1,425,066
| -70% | -$5.34M |
|
900
International Seaways
INSW
$5.42B
| $2.29M | 0.01% |
60,013
-1,639
| -3% | -$62.8K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.